Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects
Clinical trial NCT05932888 · COMPLETED
Trial details
- NCT number
- NCT05932888
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-25
- Primary completion
- 2023-08-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.